New Coronavirus Variants are Creating More Challenges to Global Healthcare System: A Brief Report on the Current Knowledge
The coronavirus is naturally mutating over time and producing new variants. Some of them are more contagious and destructive than previous strains. Also, some variants are capable of therapeutic escaping. Earlier SARS-CoV-2 variants proved that some are supercritical, and newly mutated strains are creating new challenges to the global healthcare systems. Here we aimed to evaluate different coronavirus variants and associated challenges for healthcare systems. We searched for information online and on the PubMed, Scopus, and Embase databases. We found the wild-type virus is more sensitive for neutralization and more controllable than newer variants. The Delta and Omicron variants are more highly transmissible than Alpha, Beta, and Gamma variants. Also, few strains are resistant to neutralization. Therefore, there is a chance of reinfection among the vaccinated population. The transmissibility and resistance of the recently identified Omicron variant is still unclear. The Delta variant is the most dangerous among all variants due to its high transmissibility, disease severity, and mortality rate. For poor and developing countries, oxygen supply, medication, vaccination, and device supply are challenging during epidemic waves. Slowing down the transmission, mass vaccination, vaccine redesign, re-compiling action plans, and following safety guidelines can be effective solutions to the new challenges.
Top-30
Journals
|
2
4
6
8
10
12
|
|
|
Health Science Reports
12 publications, 11.88%
|
|
|
Clinical Pathology
4 publications, 3.96%
|
|
|
Vaccines
3 publications, 2.97%
|
|
|
Journal of Medical Virology
3 publications, 2.97%
|
|
|
International Journal of Environmental Research and Public Health
2 publications, 1.98%
|
|
|
Cureus
2 publications, 1.98%
|
|
|
Frontiers in Immunology
2 publications, 1.98%
|
|
|
Heliyon
2 publications, 1.98%
|
|
|
Infection and Drug Resistance
2 publications, 1.98%
|
|
|
PLoS ONE
2 publications, 1.98%
|
|
|
JMIR Aging
1 publication, 0.99%
|
|
|
Pathogens
1 publication, 0.99%
|
|
|
Journal of Environmental and Public Health
1 publication, 0.99%
|
|
|
Frontiers in Pharmacology
1 publication, 0.99%
|
|
|
Gerontology and Geriatric Medicine
1 publication, 0.99%
|
|
|
International Journal of Molecular Sciences
1 publication, 0.99%
|
|
|
Frontiers in Public Health
1 publication, 0.99%
|
|
|
Coatings
1 publication, 0.99%
|
|
|
Processes
1 publication, 0.99%
|
|
|
Biologicals
1 publication, 0.99%
|
|
|
Gene Reports
1 publication, 0.99%
|
|
|
Radiography
1 publication, 0.99%
|
|
|
Building and Environment
1 publication, 0.99%
|
|
|
Journal of Biosafety and Biosecurity
1 publication, 0.99%
|
|
|
Virology Journal
1 publication, 0.99%
|
|
|
Frontiers in Psychiatry
1 publication, 0.99%
|
|
|
Chemical Biology and Drug Design
1 publication, 0.99%
|
|
|
Immunity, inflammation and disease
1 publication, 0.99%
|
|
|
Reviews in Medical Virology
1 publication, 0.99%
|
|
|
2
4
6
8
10
12
|
Publishers
|
5
10
15
20
25
|
|
|
Wiley
21 publications, 20.79%
|
|
|
Elsevier
16 publications, 15.84%
|
|
|
MDPI
11 publications, 10.89%
|
|
|
Springer Nature
10 publications, 9.9%
|
|
|
SAGE
9 publications, 8.91%
|
|
|
Frontiers Media S.A.
5 publications, 4.95%
|
|
|
Taylor & Francis
5 publications, 4.95%
|
|
|
Cold Spring Harbor Laboratory
5 publications, 4.95%
|
|
|
JMIR Publications
4 publications, 3.96%
|
|
|
Hindawi Limited
2 publications, 1.98%
|
|
|
Public Library of Science (PLoS)
2 publications, 1.98%
|
|
|
BMJ
2 publications, 1.98%
|
|
|
Proceedings of the National Academy of Sciences (PNAS)
1 publication, 0.99%
|
|
|
Bentham Science Publishers Ltd.
1 publication, 0.99%
|
|
|
S. Karger AG
1 publication, 0.99%
|
|
|
Medknow
1 publication, 0.99%
|
|
|
Radcliffe Media Media Ltd
1 publication, 0.99%
|
|
|
South African Medical Association NPC
1 publication, 0.99%
|
|
|
5
10
15
20
25
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.